1) aromatase inhibitor letrozole
芳香化酶抑制剂来曲唑
1.
Objective To observe effects of marvelon(desogestrel and ethinyl estradiol)and aromatase inhibitor letrozole sequential therapy on endocrine functions and fertility of women with polycystic ovary syndrome(PCOS).
目的探讨妈富隆(地索高诺酮+乙炔雌二醇)与芳香化酶抑制剂来曲唑序贯用药对多囊卵巢综合征患者内分泌及生殖功能的影响。
2) aromatase inhibitor
芳香化酶抑制剂
1.
Clinical analysis of relapsed endometrial carcinoma treated with aromatase inhibitor lantaron;
芳香化酶抑制剂治疗晚期复发性子宫内膜癌初探
2.
Objective To improve the synthetic procedure of aromatase inhibitor-anastrozole.
目的改进芳香化酶抑制剂阿那曲唑的合成工艺。
3.
Recent advances in the treatment of recombinant human growth hormone,gonadotropin-releasing hormone analogue, aromatase inhibitor in children with ISS were reviewed in detail.
目前对儿童特发性矮小的临床治疗主要集中在重组人生长激素(rhGH)、促性腺激素释放激素类似物(Gn-RHa)和芳香化酶抑制剂(AI)。
3) aromatase inhibitors
芳香化酶抑制剂
1.
Study Progress of Third-Generation Aromatase inhibitors about the effect of Ovulation Induction;
第三代芳香化酶抑制剂的促排卵作用的研究进展
2.
Clinical side effects of Aromatase Inhibitors for breast cancer;
第三代芳香化酶抑制剂临床应用的常见不良反应
3.
Advances research in third generation aromatase inhibitors in adjuvant therapy of postmenopausal women with early breast cancer;
第三代芳香化酶抑制剂在乳腺癌术后辅助治疗中的应用进展
4) aromatic cyclase inhibitor
芳香环化酶抑制剂
5) aromatase inhibitor
芳香酶抑制剂
1.
The mechanisms and development of a breast cancer drug-aromatase inhabitor were briefly reviewed, and fadrozole, as a new selective, nonsteroidal aromatase inhibitor was introduced and synthesized in this thesis.
本文对芳香酶抑制剂抗乳腺癌作用机理、分类及其发展概况作了简述,并对第二代新型芳香酶抑制剂法倔唑合成工艺进行了研究。
2.
Steroidal aromatase inhibitor can inhibit the aromatase activity, interdict the reaction, and inhibit the estrogen formation, so that it can cure the breast cancer.
甾体芳香酶抑制剂能抑制芳香酶活性,阻断芳构化反应,抑制雌激素生成,从而达到治疗乳腺癌的目的。
6) aromatase/antagonists and inhibitors
芳香酶/拮抗剂和抑制剂
补充资料:来曲唑
分子式:C17H11N5
分子量:285.10
CAS号:112809-51-5
性质:该品为白色或类白色结晶性粉末。
制备方法:暂无
用途:暂无
分子量:285.10
CAS号:112809-51-5
性质:该品为白色或类白色结晶性粉末。
制备方法:暂无
用途:暂无
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
参考词条